Page 12 - Read Online

78 Prevalence and incidence of intra- and extrahepatic complications of NAFLD in patients with type 2
diabetes mellitus
Alessandro Mantovani, Giorgia Beatrice, Roberta Stupia, Andrea Dalbeni
Hepatoma Res 2020;6:78 http://dx.doi.org/10.20517/2394-5079.2020.75

79 Current status of laparoscopic repeat liver resection for hepatocellular carcinoma
Zenichi Morise
Hepatoma Res 2020;6:79 http://dx.doi.org/10.20517/2394-5079.2020.76

80 p53 functional loss, stemness and hepatocellular carcinoma
Claude Caron de Fromentel, Massimo Levrero
Hepatoma Res 2020;6:80 http://dx.doi.org/10.20517/2394-5079.2020.77

81 Current status of laparoscopic repeat liver resection for recurrent hepatocellular carcinoma
Daisuke Hokuto, Takeo Nomi, Takahiro Yoshikawa, Yasuko Matsuo, Naoki Kamitani, Masayuki Sho
Hepatoma Res 2020;6:81 http://dx.doi.org/10.20517/2394-5079.2020.78

82 Diabetes and NAFLD: a high-risk cohort with definite therapeutic potential
Lucia Brodosi, Alessandra Musio, Francesca Alessandra Barbanti, Dorina Mita, Giulio Marchesini, Maria Letizia
Petroni
Hepatoma Res 2020;6:82 http://dx.doi.org/10.20517/2394-5079.2020.88

83 Sex disparity in hepatocellular carcinoma owing to NAFLD and non-NAFLD etiology: epidemiological
findings and pathobiological mechanisms
Amedeo Lonardo, Stefano Ballestri, Pierce K. H. Chow, Ayako Suzuki
Hepatoma Res 2020;6:83 http://dx.doi.org/10.20517/2394-5079.2020.89

84 Nonalcoholic fatty liver disease in lean subjects: is it all metabolic-associated fatty liver disease?
Mariana Verdelho Machado
Hepatoma Res 2020;6:84 http://dx.doi.org/10.20517/2394-5079.2020.90

85 Genetic risk factors associated with NAFLD
Dong Yun Kim, Jun Yong Park
Hepatoma Res 2020;6:85 http://dx.doi.org/10.20517/2394-5079.2020.96